Use search to browse all 100+ peptides
GHRH (1-29), GRF 1-29 NH2, Sermorelin acetate
A synthetic 29-amino acid analog of growth hormone-releasing hormone that stimulates pituitary gland to release growth hormone.
| Route | |
|---|---|
|
Intravenous (IV)
1 mcg/kg
|
|
|
Subcutaneous (SC)
30 mcg/kg daily
|
How It Works: Sermorelin acts as an agonist at the growth hormone-releasing hormone (GHRH) receptor in the anterior pituitary, mimicking natural GHRH to stimulate the pulsatile release of growth hormone.
Uçaktürk. Ebru E; Nemutlu. Emirhan E
Scientists created a super‑sensitive urine test that can spot growth‑hormone‑releasing peptides like sermorelin at very low levels (0.5 ng/mL). The method uses tiny‑scale liquid chromatography and high‑resolution mass spectrometry, and it meets anti‑doping lab standards.
Sigdel. Madan M; Fakir. Saikat S; Sarker. Md Matiur Rahman MMR; Barabutis. Nekta...
A lab study found that a peptide that blocks growth‑hormone‑releasing hormone (GHRH) can trigger the cell‑clean‑up process called autophagy in certain cancer cells that have GHRH receptors, but it does nothing in cells without those receptors.
Gesmundo. Iacopo I; Pedrolli. Francesca F; Giglioli. Francesca Romana FR; Jazaj....
Scientists found that drugs that block the hormone that normally tells the body to release growth hormone can make lung cancer cells more vulnerable to radiation in lab dishes, but this research used special lab compounds, not the growth‑hormone‑releasing peptide sermorelin, and it’s far from any real‑world self‑experiment or treatment plan.